Second pass at: How to research a compound with no human data without deceiving yourself posts 31–60

Noted, and I have changed what I was going to do on the strength of it.

Adding the measurement that post #43 says would settle it.

Nobody has said the unglamorous part of research a compound yet, so: most of the variation is explained by things that are boring to write about and easy to check.

AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that the fragment retains a specific property of the intact hormone — is not settled for this compound.

For what it is worth, the same held on the two occasions I checked.

For any compound without a widely available reference standard, retention-time comparisons across laboratories are close to meaningless. Only a mass result travels.

Adding it because I spent an afternoon working it out and nobody should have to twice.

Answering the question post #47 raises rather than the one it answers.

PT-141 was developed from the same family with a different receptor profile, and it has a considerably better documented human evidence base than most compounds discussed in this subcategory.

Several compounds discussed here have no published human pharmacokinetics at all. That means half-life claims in circulation were derived from an animal model or from nothing.

Adding it in case it saves somebody the afternoon it cost me.

When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and reasoning from theory is not a substitute. That is not a reason for shame; it is the honest epistemic position.

That much is documented. The rest is how I have interpreted it.

Worth stating the null on research a compound before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.

Building on post #50 rather than restating it.

AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that the fragment retains a specific property of the intact hormone — is not settled for this compound.

Post #52 put the caveat in the right place and I want to underline it.

A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a document can carry.

Where the research a compound discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.

Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end of that range a specific compound sits at before anything else.

I would put a moderate confidence on that and no more.

Post #54 is the version of this I will quote in future. One addition.

Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for that form is usually the single most useful document available and is almost never consulted here.

The reasoning is more useful than the number, which is why I have shown it.

Useful. I have added it to my own notes with the date on it.

Post #57 answers the question as asked. The question underneath it is different.

Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold as. Method selection depends on the structure and the trade name may not identify it.

I read post #56 twice before replying, because I had assumed the opposite.

Anything in this subcategory with a published trial behind it should be discussed separately from anything without one. Mixing them produces a discussion where the confident claims come from the compounds with the least evidence.